Literature DB >> 19188477

Anticoagulants and pregnancy: when are they safe?

Paul S Gibson1, Raymond Powrie.   

Abstract

Prescribing anticoagulants to pregnant women can be difficult and stressful. Fortunately, low-molecular-weight heparins (LMWHs) and unfractionated heparin are quite safe and efficacious when properly selected, dosed, and monitored. Maternal and fetal concerns must be considered at all times, with a careful assessment of the risks and benefits of anticoagulant therapy in each patient. Further research should help to clarify who should receive thromboprophylaxis, how to prevent adverse pregnancy outcomes in women with various thrombophilias, and how best to treat pregnant women who have a prosthetic heart valve.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19188477     DOI: 10.3949/ccjm.75a.072272

Source DB:  PubMed          Journal:  Cleve Clin J Med        ISSN: 0891-1150            Impact factor:   2.321


  4 in total

Review 1.  New frontiers with bemiparin: use in special populations.

Authors:  Jordi Fontcuberta Boj
Journal:  Drugs       Date:  2010-12-14       Impact factor: 9.546

2.  [Anticoagulation strategies in patients with deep vein thrombosis and pulmonary artery embolisms].

Authors:  P W Radke; M Möckel
Journal:  Herz       Date:  2018-02       Impact factor: 1.443

Review 3.  Headache in pregnancy: an approach to emergency department evaluation and management.

Authors:  Jessica C Schoen; Ronna L Campbell; Annie T Sadosty
Journal:  West J Emerg Med       Date:  2015-02-25

4.  How can Secondary Thromboprophylaxis in High-Risk Pregnant Patients be Improved?

Authors:  Lucia Stanciakova; Miroslava Dobrotova; Pavol Holly; Jana Zolkova; Lubica Vadelova; Ingrid Skornova; Jela Ivankova; Matej Samos; Tomas Bolek; Marian Grendar; Jan Danko; Peter Kubisz; Jan Stasko
Journal:  Clin Appl Thromb Hemost       Date:  2022 Jan-Dec       Impact factor: 2.389

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.